B. C. De-aragao, H. A. Rodrigues, P. A. Valadao, W. Camargo, L. A. Naves et al., Changes in structure and function of diaphragm neuromuscular junctions from BACHD mouse model for Huntington's disease, Neurochem Int, vol.93, pp.64-72, 2016.

J. Arenas, Y. Campos, R. Ribacoba, M. A. Martin, J. C. Rubio et al., Complex I defect in muscle from patients with Huntington's disease, Ann Neurol, vol.43, pp.397-400, 1998.

I. Arnulf, J. Nielsen, E. Lohmann, J. Schiefer, J. Schieffer et al., Rapid eye movement sleep disturbances in Huntington disease, Arch. Neurol, vol.65, pp.482-488, 2008.

G. Avila, E. H. Lee, C. F. Perez, P. D. Allen, and R. T. Dirksen, FKBP12 binding to RyR11 modulates excitation-contraction coupling in mouse skeletal myotubes, J. Biol. Chem, vol.278, pp.22600-22608, 2003.

N. A. Aziz, J. M. Van-der-burg, G. B. Landwehrmeyer, P. Brundin, T. Stijnen et al., Weight loss in Huntington disease increases with higher CAG repeat number, Neurology, vol.71, pp.1506-1513, 2008.

N. A. Aziz, G. V. Anguelova, J. Marinus, J. G. Van-dijk, and R. A. Roos, Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease, Eur. J. Neurol, vol.17, pp.1068-1074, 2010.

B. ,

L. Babonneix, Quelques étapes dans l'histoire de la chorée, Le Monde médical, vol.35, pp.852-67, 1925.

A. J. Bakker, S. I. Head, and D. G. Stephenson, Measurement of membrane potential and myoplasmic [Ca2+] in developing rat myotubes at rest and in response to stimulation, Cell Calcium, vol.19, pp.409-418, 1996.

S. S. Baig, M. Strong, and O. W. Quarrell, The global prevalence of Huntington's disease: a systematic review and discussion, Neurodegenerative Disease Management, vol.6, issue.4, pp.331-343, 2016.

F. K. Baine, A. Krause, and L. J. Greenberg, The Frequency of Huntington Disease and Huntington Disease-Like 2 in the South African Population, Neuroepidemiology, vol.46, issue.3, pp.198-202, 2016.

K. J. Bär, M. K. Boettger, J. Andrich, J. T. Epplen, F. Fischer et al., Cardiovagal modulation upon postural change is altered in Huntington's disease, Eur. J. Neurol, vol.15, pp.869-871, 2008.

C. Barlowe, COPII and selective export from the endoplasmic reticulum, Biochim. Biophys. Acta, vol.1404, pp.67-76, 1998.

G. Bates, Huntingtin aggregation and toxicity in Huntington's disease, Lancet, vol.361, pp.1642-1644, 2003.

G. P. Bates, R. Dorsey, J. F. Gusella, M. R. Hayden, C. Kay et al., Huntington disease. Nat Rev Dis Primers 1, p.15005, 2015.

S. Baudic, P. Maison, G. Dolbeau, M. Boissé, P. Bartolomeo et al., Cognitive impairment related to apathy in early Huntington's disease, Dement Geriatr Cogn Disord, vol.21, pp.316-321, 2006.

P. Bauer, F. Laccone, A. Rolfs, U. Wüllner, S. Bösch et al., Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype, J. Med. Genet, vol.41, pp.230-232, 2004.

N. A. Beard, M. M. Sakowska, A. F. Dulhunty, and D. R. Laver, Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels, Biophys. J, vol.82, pp.310-320, 2002.

N. Bechtel, R. I. Scahill, H. D. Rosas, T. Acharya, S. J. Van-den-bogaard et al., Tapping linked to function and structure in premanifest and symptomatic Huntington disease, Neurology, vol.75, pp.2150-2160, 2010.

J. Bell, Nervous disease and muscular dystrophies. Part I. Huntington's chorea, p.67, 1934.

I. Bezprozvanny, Calcium signaling and neurodegenerative diseases, Trends Mol Med, vol.15, pp.89-100, 2009.

E. Bianconi, A. Piovesan, F. Facchin, A. Beraudi, R. Casadei et al., An estimation of the number of cells in the human body, Annals of human biology, vol.40, issue.6, pp.463-471, 2013.

P. R. Billings, M. A. Kohn, M. De-cuevas, J. Beckwith, J. S. Alper et al., Discrimination as a consequence of genetic testing, Am. J. Hum. Genet, vol.50, pp.476-482, 1992.

T. Blekher, S. A. Johnson, J. Marshall, K. White, S. Hui et al., Saccades in presymptomatic and early stages of Huntington disease, vol.67, pp.394-399, 2006.

T. M. Blekher, R. D. Yee, S. C. Kirkwood, A. M. Hake, J. C. Stout et al., Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington's disease, Vision Res, vol.44, pp.2729-2736, 2004.

B. A. Block, T. Imagawa, K. P. Campbell, and C. Franzini-armstrong, Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle, J. Cell Biol, vol.107, pp.2587-2600, 1988.

S. C. Bodine and L. M. Baehr, Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1, Am. J. Physiol. Endocrinol. Metab, vol.307, pp.469-484, 2014.

S. Bohlega, A. Al-tahan, M. Kambouris, and M. Divakaran, Neurodegenerative Huntington-like disorder, Mov. Disord, vol.16, pp.533-534, 2001.

Y. Bombard, G. Veenstra, J. M. Friedman, S. Creighton, L. Currie et al., Perceptions of genetic discrimination among people at risk for Huntington's disease: a cross sectional survey, BMJ, vol.338, p.2175, 2009.

P. Bonaldo and M. Sandri, Cellular and molecular mechanisms of muscle atrophy, Disease Models & Mechanisms, vol.6, pp.25-39, 2013.

C. M. Bonelli, R. M. Bonelli, M. Eichinger, K. Suppan, F. Reisecker et al., Bone density and bone turnover in Huntington's disease Osteoporosis int, vol.13, pp.64-64, 2002.

P. Braubach, M. Orynbayev, Z. Andronache, T. Hering, G. B. Landwehrmeyer et al., Altered Ca(2+) signaling in skeletal muscle fibers of the R6/2 mouse, a model of Huntington's disease, J. Gen. Physiol, vol.144, pp.393-413, 2014.

E. Buck, M. Zügel, U. Schumann, T. Merz, A. M. Gumpp et al., High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory function, PLoS ONE, vol.12, p.175248, 2017.

M. Buckingham, Myogenic progenitor cells and skeletal myogenesis in vertebrates, Curr. Opin. Genet. Dev, vol.16, pp.525-532, 2006.

J. M. Van-der-burg, M. Björkqvist, and P. Brundin, Beyond the brain: widespread pathology in Huntington's disease, Lancet Neurol, vol.8, pp.765-774, 2009.

M. E. Busse, G. Hughes, C. M. Wiles, and A. E. Rosser, Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington's disease, J. Neurol, vol.255, 2008.

C. ,

A. J. Calder, J. Keane, A. W. Young, A. D. Lawrence, S. Mason et al., The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease, Neuropsychologia, vol.48, pp.2719-2729, 2010.

J. B. Carroll, G. P. Bates, J. Steffan, C. Saft, and S. J. Tabrizi, Treating the whole body in Huntington's disease, Lancet Neurol, vol.14, pp.1135-1142, 2015.

E. Cattaneo, D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri et al., Loss of normal huntingtin function: new developments in Huntington's disease research, Trends Neurosci, vol.24, pp.182-188, 2001.

J. P. Caviston, A. L. Zajac, M. Tokito, and E. L. Holzbaur, Huntingtin coordinates the dynein-mediated dynamic positioning of endosomes and lysosomes, Mol. Biol. Cell, vol.22, pp.478-492, 2011.

C. Cepeda, N. Wu, V. M. André, D. M. Cummings, and M. S. Levine, The corticostriatal pathway in Huntington's disease, Prog. Neurobiol, vol.81, pp.253-271, 2007.

W. K. Chandler, A. Hirota, D. S. Jong, and P. C. Pape, Measurement of calcium release from the sarcoplasmic reticulum into the myoplasm of frog cut muscle fibers, Jpn. J. Physiol, vol.43, pp.77-81, 1993.

J. M. Charcot and . Malade, Chorée chronique avec hérédité similaire (chorée de Huntington), Leçons du mardi à la Salpêtrière: Policlinique 1887-88, 1888-89: notes de cours de Blin, Charcot et Colin. Aux bureaux du Progrès médical, pp.429-441, 1889.

R. K. Chaturvedi, P. Adhihetty, S. Shukla, T. Hennessy, N. Calingasan et al., Impaired PGC-1alpha function in muscle in Huntington's disease, Hum Mol Genet, vol.18, pp.3048-3065, 2009.

R. K. Chaturvedi, N. Y. Calingasan, L. Yang, T. Hennessey, A. Johri et al., Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation, Hum. Mol. Genet, vol.19, pp.3190-3205, 2010.

X. Chen, J. Wu, S. Lvovskaya, E. Herndon, C. Supnet et al., Dantrolene is neuroprotective in Huntington's disease transgenic mouse model, Mol Neurodegener, vol.6, p.81, 2011.

A. Ciammola, J. Sassone, L. Alberti, G. Meola, E. Mancinelli et al., Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects, Cell Death Differ, vol.13, pp.2068-2078, 2006.

A. Ciammola, J. Sassone, M. Sciacco, N. E. Mencacci, M. Ripolone et al., Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease, Mov. Disord, vol.26, pp.130-137, 2011.

N. F. Clarke, L. B. Waddell, S. T. Cooper, M. Perry, R. L. Smith et al., Recessive mutations in RYR11 are a common cause of congenital fiber type disproportion, Hum. Mutat, vol.31, pp.1544-1550, 2010.

E. Colin, D. Zala, G. Liot, H. Rangone, M. Borrell-pagès et al., Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons, EMBO J, vol.27, pp.2124-2134, 2008.

G. Cooper, The Cell : a molecular approach, 2000.

H. E. Crawford, N. Z. Hobbs, R. Keogh, D. R. Langbehn, C. Frost et al., Corpus callosal atrophy in premanifest and early Huntington's disease, J Huntingtons Dis, vol.2, pp.517-526, 2013.

A. M. Cuervo and S. Zhang, Selective autophagy and Huntingtin: learning from disease, Cell Cycle, vol.14, pp.1617-1618, 2015.

C. B. Davenport and E. B. Muncey, Huntington's chorea in relation to heredity and eugenics, American Journal of Psychiatry, vol.73, issue.2, pp.195-222, 1916.

A. W. Deckel, R. Elder, and G. Fuhrer, Biphasic developmental changes in Ca2+/calmodulin-dependent proteins in R6/2 Huntington's disease mice, Neuroreport, vol.13, pp.707-711, 2002.

B. Dehay, C. Weber, Y. Trottier, and A. Bertolotti, Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity, Biotechnol J, vol.2, pp.559-564, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00190896

P. Deleplanque, Études tératologiques. I. Des Difformités congénitales produites sur le foetus par la contraction musculaire, 1895.

K. Dieterich, S. Quijano-roy, N. Monnier, J. Zhou, J. Fauré et al., The neuronal endopeptidase ECEL1 is associated with a distinct form of recessive distal arthrogryposis, Hum. Mol. Genet, vol.22, pp.1483-1492, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00904747

M. Difiglia, E. Sapp, K. O. Chase, S. W. Davies, G. P. Bates et al., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, vol.277, pp.1990-1993, 1997.

L. Djoussé, B. Knowlton, L. A. Cupples, K. Marder, I. Shoulson et al., Weight loss in early stage of Huntington's disease, Neurology, vol.59, pp.1325-1330, 2002.

B. D. Dufour, C. A. Smith, R. L. Clark, T. R. Walker, and J. L. Mcbride, Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice, Mol Ther, vol.22, pp.797-810, 2014.

E. Van-duijn, E. M. Kingma, and R. C. Van-der-mast, Psychopathology in verified Huntington's disease gene carriers, J Neuropsychiatry Clin Neurosci, vol.19, pp.441-448, 2007.

E. Van-duijn, D. Craufurd, A. A. Hubers, E. J. Giltay, R. Bonelli et al., Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY), J. Neurol. Neurosurg. Psychiatr, vol.85, pp.1411-1418, 2014.

E. M. Dumas, S. J. Van-den-bogaard, H. A. Middelkoop, and R. A. Roos, A review of cognition in Huntington's disease, Front Biosci (Schol Ed), vol.5, pp.1-18, 2013.

M. Duyao, C. Ambrose, R. Myers, A. Novelletto, F. Persichetti et al., Trinucleotide repeat length instability and age of onset in Huntington's disease, Nat. Genet, vol.4, pp.387-392, 1993.

M. P. Duyao, A. B. Auerbach, A. Ryan, F. Persichetti, G. T. Barnes et al., Inactivation of the mouse Huntington's disease gene homolog Hdh, Science, vol.269, pp.407-410, 1995.

J. E-von-der-ecken, M. Müller, W. Lehman, D. J. Manstein, P. A. Penczek et al., Structure of the F-actin-tropomyosin complex, Nature, vol.519, pp.114-117, 2015.

C. M. Eddy and H. E. Rickards, Theory of mind can be impaired prior to motor onset in Huntington's disease, Neuropsychology, vol.29, pp.792-798, 2015.

C. Edmonds, Huntington's chorea, dysphagia and death, Med. J. Aust, vol.2, pp.273-274, 1966.

R. G. Efremov, A. Leitner, R. Aebersold, and S. Raunser, Architecture and conformational switch mechanism of the ryanodine receptor, Nature, vol.517, pp.39-43, 2015.

D. E. Ehrnhoefer, N. H. Skotte, S. Ladha, Y. T. Nguyen, X. Qiu et al., p53 increases caspase-6 expression and activation in muscle tissue expressing mutant huntingtin, Hum Mol Genet, vol.23, pp.717-729, 2014.

M. El-daher, E. Hangen, J. Bruyère, G. Poizat, I. Al-ramahi et al., Huntingtin proteolysis releases nonpolyQ fragments that cause toxicity through dynamin 1 dysregulation, EMBO J, vol.34, pp.2255-2271, 2015.

S. Elias, M. S. Thion, H. Yu, C. M. Sousa, C. Lasgi et al., , 2014.

, Huntingtin regulates mammary stem cell division and differentiation, Stem Cell Reports, vol.2, pp.491-506

A. Engel and C. Franzini-armstrong, Myology: basic and clinical, 1994.

S. J. Evans, I. Douglas, M. D. Rawlins, N. S. Wexler, S. J. Tabrizi et al., Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records, J. Neurol. Neurosurg. Psychiatr, vol.84, pp.1156-1160, 2013.

L. A. Farrer and F. J. Meaney, An anthropometric assessment of Huntington's disease patients and families, Am. J. Phys. Anthropol, vol.67, pp.185-194, 1985.

L. A. Farrer, Y. , and P. L. , Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease, Am. J. Med. Genet, vol.21, pp.307-316, 1985.

R. Fekete, J. , and J. , Upper facial chorea in Huntington disease, J Clin Mov Disord, vol.1, p.7, 2014.

M. Ferns, M. Deiner, and Z. Hall, Agrin-induced acetylcholine receptor clustering in mammalian muscle requires tyrosine phosphorylation, J. Cell Biol, vol.132, pp.937-944, 1996.

A. Fourest-lieuvin, J. Rendu, A. Osseni, K. Pernet-gallay, D. Rossi et al., Role of triadin in the organization of reticulum membrane at the muscle triad, J. Cell. Sci, vol.125, pp.3443-3453, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00763148

M. Fosset, E. Jaimovich, E. Delpont, and M. Lazdunski, 3H]nitrendipine receptors in skeletal muscle, J. Biol. Chem, vol.258, pp.6086-6092, 1983.

C. Franzini-armstrong, L. J. Kenney, and E. Varriano-marston, The structure of calsequestrin in triads of vertebrate skeletal muscle: a deep-etch study, J. Cell Biol, vol.105, pp.49-56, 1987.

Y. Fu and T. Hong, BIN1 regulates dynamic t-tubule membrane, Biochim. Biophys. Acta, vol.1863, pp.1839-1847, 2016.

M. Gaburjakova, J. Gaburjakova, S. Reiken, F. Huang, S. O. Marx et al., FKBP12 binding modulates ryanodine receptor channel gating, J. Biol. Chem, vol.276, pp.16931-16935, 2001.

J. Gafni and L. M. Ellerby, Calpain activation in Huntington's disease, J. Neurosci, vol.22, pp.4842-4849, 2002.

J. Gafni, E. Hermel, J. E. Young, C. L. Wellington, M. R. Hayden et al., Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus, J. Biol. Chem, vol.279, pp.20211-20220, 2004.

A. Garbino, R. J. Van-oort, S. S. Dixit, A. P. Landstrom, M. J. Ackerman et al., Molecular evolution of the junctophilin gene family, Physiol. Genomics, vol.37, pp.175-186, 2009.

J. García, T. Tanabe, and K. G. Beam, Relationship of calcium transients to calcium currents and charge movements in myotubes expressing skeletal and cardiac dihydropyridine receptors, J. Gen. Physiol, vol.103, pp.125-147, 1994.

J. García and K. G. Beam, Measurement of calcium transients and slow calcium current in myotubes, J. Gen. Physiol, vol.103, pp.107-123, 1994.

L. R. Gauthier, B. C. Charrin, M. Borrell-pagès, J. P. Dompierre, H. Rangone et al., Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules, Cell, vol.118, pp.127-138, 2004.

A. Gelman, M. Rawet-slobodkin, and Z. Elazar, Huntingtin facilitates selective autophagy, Nat. Cell Biol, vol.17, pp.214-215, 2015.

A. Des-georges, O. B. Clarke, R. Zalk, Q. Yuan, K. J. Condon et al., Structural Basis for Gating and Activation of RyR1, Cell, vol.167, pp.145-157, 2016.

N. Georgiou-karistianis, J. C. Stout, D. Domínguez, J. F. Carron, S. P. Ando et al., Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study, Hum Brain Mapp, vol.35, pp.1847-1864, 2014.

Z. Z. Gizatullina, K. S. Lindenberg, P. Harjes, Y. Chen, C. M. Kosinski et al., Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice, Ann Neurol, vol.59, pp.407-411, 2006.

J. D. Godin, K. Colombo, M. Molina-calavita, G. Keryer, D. Zala et al., Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis, Neuron, vol.67, pp.392-406, 2010.

A. M. Goh, E. Chiu, O. Yastrubetskaya, C. Erwin, J. K. Williams et al., Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study, Hd Investigators Of The Huntington Study Group, vol.17, pp.115-121, 2013.

Y. P. Goldberg, D. W. Nicholson, D. M. Rasper, M. A. Kalchman, H. B. Koide et al., Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract, Nat. Genet, vol.13, pp.442-449, 1996.

C. V. Golding, C. Danchaivijitr, T. L. Hodgson, S. J. Tabrizi, and C. Kennard, Identification of an oculomotor biomarker of preclinical Huntington disease, Neurology, vol.67, pp.485-487, 2006.

M. Gonzalez-freire, R. D. Semba, C. Ubaida-mohien, E. Fabbri, P. Scalzo et al., The Human Skeletal Muscle Proteome Project: a reappraisal of the current literature, J Cachexia Sarcopenia Muscle, vol.8, pp.5-18, 2017.

A. M. Gordon, L. Quinn, R. Reilmann, and K. Marder, Coordination of prehensile forces during precision grip in Huntington's disease, Exp. Neurol, vol.163, pp.136-148, 2000.

T. Grandmougin, C. Bourdet, and J. M. Gurruchaga, De la danse de Saint Guy à la chorée de Huntington: rappels sur l'émergence d'un concept médical, MS. Médecine sciences, vol.13, issue.6-7, pp.850-854, 1997.

P. Grumati, L. Coletto, P. Sabatelli, M. Cescon, A. Angelin et al., Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration, Nat. Med, vol.16, pp.1313-1320, 2010.

P. Grumati, L. Coletto, M. Sandri, and P. Bonaldo, Autophagy induction rescues muscular dystrophy, Autophagy, vol.7, pp.426-428, 2011.

A. Guerrero-hernandez, G. Avila, and A. Rueda, Ryanodine receptors as leak channels, Eur J Pharmacol, vol.739, pp.26-38, 2014.

J. L. Haines and P. M. Conneally, Causes of death in Huntington disease as reported on death certificates, Genet. Epidemiol, vol.3, pp.417-423, 1986.

J. G. Hall, Pena-Shokeir phenotype (fetal akinesia deformation sequence) revisited, Birth Defects Res. Part A Clin. Mol. Teratol, vol.85, pp.677-694, 2009.

J. G. Hall, Arthrogryposis (multiple congenital contractures): diagnostic approach to etiology, classification, genetics, and general principles, Eur J Med Genet, vol.57, pp.464-472, 2014.

J. G. Hall and J. Kiefer, Arthrogryposis as a Syndrome, Gene Ontology Analysis. Mol Syndromol, vol.7, pp.101-109, 2016.

Z. W. Hall and J. R. Sanes, Synaptic structure and development: the neuromuscular junction, Cell, vol.72, pp.99-121, 1993.

T. Haremaki, A. Deglincerti, and A. H. Brivanlou, Huntingtin is required for ciliogenesis and neurogenesis during early Xenopus development, Dev. Biol, vol.408, pp.305-315, 2015.

P. S. Harper, The epidemiology of Huntington's disease, Huntington's Disease, 2002.

P. S. Harper, S. Gevers, G. De-wert, S. Creighton, Y. Bombard et al., Genetic testing and Huntington's disease: issues of employment, Lancet Neurol, vol.3, pp.249-252, 2004.

E. Hart, H. Middelkoop, C. K. Jurgens, M. W. Witjes-ané, and R. A. Roos, Seven-year clinical follow-up of premanifest carriers of Huntington's disease, PLoS Curr, vol.3, 1288.

L. Hartelius, M. Jonsson, A. Rickeberg, and K. Laakso, Communication and Huntington's disease: qualitative interviews and focus groups with persons with Huntington's disease, family members, and carers, Int J Lang Commun Disord, vol.45, pp.381-393, 2010.

T. Hashimoto, Y. , and N. , A comparison of the regularity of involuntary muscle contractions in vascular chorea with that in Huntington's chorea, hemiballism and parkinsonian tremor, J Neurol Sci, vol.125, pp.87-94, 1994.

M. R. Hayden, J. M. Macgregor, and P. H. Beighton, The prevalence of Huntington's chorea in South Africa, S. Afr. Med. J, vol.58, pp.193-196, 1980.

K. W. Heathfield, Huntington's chorea: a centenary review, Postgrad Med J, vol.49, pp.32-45, 1973.

A. Heemskerk and R. A. Roos, Aspiration pneumonia and death in Huntington's disease, PLoS Curr, vol.4, p.1293, 2012.

L. Her and L. S. Goldstein, Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin, J. Neurosci, vol.28, pp.13662-13672, 2008.

L. Her, J. Lin, M. Fu, Y. Chang, C. Li et al., The Differential Profiling of UbiquitinProteasome and Autophagy Systems in Different Tissues before the Onset of Huntington's Disease Models, vol.25, pp.481-490, 2015.

T. Hering, P. Braubach, G. B. Landwehrmeyer, K. S. Lindenberg, and W. Melzer, Fast-to-Slow Transition of Skeletal Muscle Contractile Function and Corresponding Changes in Myosin Heavy and Light Chain Formation in the R6/2 Mouse Model of Huntington's Disease, PLoS ONE, vol.11, 2016.

E. Hermel, J. Gafni, S. S. Propp, B. R. Leavitt, C. L. Wellington et al., Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease, Cell Death Differ, vol.11, pp.424-438, 2004.

S. L. Hicks, M. P. Robert, C. V. Golding, S. J. Tabrizi, and C. Kennard, Oculomotor deficits indicate the progression of Huntington's disease. Prog, Brain Res, vol.171, pp.555-558, 2008.

M. Hinckelmann, A. Virlogeux, C. Niehage, C. Poujol, D. Choquet et al., Self-propelling vesicles define glycolysis as the minimal energy machinery for neuronal transport, Nat Commun, vol.7, p.13233, 2016.

Y. Hirata, M. Brotto, N. Weisleder, Y. Chu, P. Lin et al., Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes, Biophys. J, vol.90, pp.4418-4427, 2006.

J. G. Hodgson, N. Agopyan, C. A. Gutekunst, B. R. Leavitt, F. Lepiane et al., A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration, Neuron, vol.23, pp.181-192, 1999.

S. E. Holmes, E. O'hearn, A. Rosenblatt, C. Callahan, H. S. Hwang et al., A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2, Nat. Genet, vol.29, pp.377-378, 2001.

V. Homberg and H. W. Lange, Central motor conduction to hand and leg muscles in Huntington's disease, Mov Disord, vol.5, pp.214-218, 1990.

V. Homberg and J. Huttunen, Muscle tone in Huntington's disease, J Neurol Sci, vol.121, pp.147-154, 1994.

T. Hoppitt, H. Pall, M. Calvert, P. Gill, G. Yao et al., A systematic review of the incidence and prevalence of long-term neurological conditions in the UK, Neuroepidemiology, vol.36, pp.19-28, 2011.

K. F. Hoth, J. S. Paulsen, D. J. Moser, D. Tranel, L. A. Clark et al., Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities, J Clin Exp Neuropsychol, vol.29, pp.365-376, 2007.

W. H. Howell and J. Fulton, Textbook of Physiology, p.545, 1949.

A. A. Hubers, E. Van-duijn, R. A. Roos, D. Craufurd, H. Rickards et al., & REGISTRY investigators of the European Huntington's Disease Network, Journal of affective disorders, vol.151, issue.1, pp.248-258, 2013.

, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, vol.72, pp.971-983, 1993.

G. Huntington, Medical and Surgical Reporter. On Chorea, pp.320-321, 1872.

J. Huttunen and V. Homberg, EMG responses in leg muscles to postural perturbations in Huntington's disease, J Neurol Neurosurg Psychiatry, vol.53, pp.55-62, 1990.

, J

J. Jankovic, C. Kenney, S. Grafe, R. Goertelmeyer, and G. Comes, Relationship between various clinical outcome assessments in patients with blepharospasm, Mov. Disord, vol.24, pp.407-413, 2009.

I. Janssen, S. B. Heymsfield, Z. M. Wang, R. , and R. , Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr, J. Appl. Physiol, vol.89, pp.81-88, 2000.

A. A. Kabbara, A. , and D. G. , Measurement of sarcoplasmic reticulum Ca2+ content in intact amphibian skeletal muscle fibres with 4-chloro-m-cresol, Cell Calcium, vol.25, pp.227-235, 1999.

S. Kakizawa, S. Moriguchi, A. Ikeda, M. Iino, and H. Takeshima, Functional crosstalk between cell-surface and intracellular channels mediated by junctophilins essential for neuronal functions, Cerebellum, vol.7, pp.385-391, 2008.

M. Kambouris, S. Bohlega, A. Al-tahan, and B. F. Meyer, Localization of the gene for a novel autosomal recessive neurodegenerative Huntington-like disorder to 4p15.3, Am. J. Hum. Genet, vol.66, pp.445-452, 2000.

N. Kanzato, M. Saito, T. Horikiri, Y. Komine, M. Nakagawa et al., Atypical rigid form of Huntington's disease: a case with peripheral amyotrophy and congenital defects of a lower limb, Intern Med, vol.37, pp.978-981, 1998.

R. J. Khairallah, G. Shi, F. Sbrana, B. L. Prosser, C. Borroto et al., Microtubules underlie dysfunction in duchenne muscular dystrophy, Sci Signal, vol.5, p.56, 2012.

Y. J. Kim, Y. Yi, E. Sapp, Y. Wang, B. Cuiffo et al., Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis, Proc. Natl. Acad. Sci. U.S.A, vol.98, pp.12784-12789, 2001.

A. Klein, S. Lillis, I. Munteanu, M. Scoto, H. Zhou et al., Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies, Hum. Mutat, vol.33, pp.981-988, 2012.

J. Kobal, Z. Melik, K. Cankar, F. F. Bajrovic, B. Meglic et al., Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease, Acta Neurol. Scand, vol.121, pp.392-399, 2010.

C. M. Kosinski, C. Schlangen, F. N. Gellerich, Z. Gizatullina, M. Deschauer et al., Myopathy as a first symptom of Huntington's disease in a Marathon runner, Mov Disord, vol.22, pp.1637-1640, 2007.

A. Krause, C. Mitchell, F. Essop, S. Tager, J. Temlett et al., Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype, Am. J. Med. Genet. B Neuropsychiatr. Genet, vol.168, pp.573-585, 2015.

A. T. Labadorf and R. H. Myers, Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing, PLoS ONE, vol.10, 2015.

U. K. Laemmli, Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.227, pp.680-685, 1970.

G. Lafargue and A. Sirigu, Sensation of effort is altered in Huntington's disease, Neuropsychologia, vol.40, pp.1654-1661, 2002.

N. M. Lali?, J. Mari?, M. Svetel, A. Joti?, E. Stefanova et al., Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion, Arch. Neurol, vol.65, pp.476-480, 2008.

G. D. Lamb and D. G. Stephenson, Effects of FK506 and rapamycin on excitationcontraction coupling in skeletal muscle fibres of the rat, J. Physiol, vol.494, pp.569-576, 1996.

G. D. Lamb, Excitation-contraction coupling in skeletal muscle: comparisons with cardiac muscle, Clin. Exp. Pharmacol. Physiol, vol.27, pp.216-224, 2000.

A. P. Landstrom, D. L. Beavers, and X. H. Wehrens, The junctophilin family of proteins: from bench to bedside, Trends Mol Med, vol.20, pp.353-362, 2014.

J. T. Lanner, D. K. Georgiou, A. D. Joshi, and S. L. Hamilton, Ryanodine Receptors: Structure, Expression, Molecular Details, and Function in Calcium Release, Cold Spring Harbor Perspectives in Biology, vol.2, pp.3996-003996, 2010.

D. J. Lanska, George Huntington (1850-1916) and hereditary chorea, J Hist Neurosci, vol.9, pp.76-89, 2000.

D. J. Lanska, M. J. Lanska, L. Lavine, and B. S. Schoenberg, Conditions associated with Huntington's disease at death. A case-control study, Arch. Neurol, vol.45, pp.878-880, 1988.

D. J. Lanska, L. Lavine, M. J. Lanska, and B. S. Schoenberg, Huntington's disease mortality in the United States, Neurology, vol.38, pp.769-772, 1988.

A. Laquérriere, J. Maluenda, A. Camus, L. Fontenas, K. Dieterich et al., Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects, Hum. Mol. Genet, vol.23, pp.2279-2289, 2014.

I. U. Larsen, T. Vinther-jensen, J. E. Nielsen, A. Gade, and A. Vogel, Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington's Disease, PLoS Curr, vol.8, 2016.

S. H. Lecker, A. L. Goldberg, M. , and W. E. , Protein degradation by the ubiquitinproteasome pathway in normal and disease states, J. Am. Soc. Nephrol, vol.17, pp.1807-1819, 2006.

A. L. Lee, H. M. Ung, L. P. Sands, and E. A. Kikis, A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles, PLoS ONE, vol.12, 2017.

A. Lekoubou, J. B. Echouffo-tcheugui, and A. P. Kengne, Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review, BMC Public Health, vol.14, p.653, 2014.

J. W. Linsley, I. Hsu, W. Wang, and J. Y. Kuwada, Transport of the alpha subunit of the L-type calcium channel through the sarcoplasmic reticulum occurs prior to localization to triads and requires the beta subunit but not Stac3 in skeletal muscles, Traffic, 2017.

R. Lodi, A. H. Schapira, D. Manners, P. Styles, N. W. Wood et al., Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy, Ann Neurol, vol.48, pp.72-76, 2000.

O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem, vol.193, pp.265-275, 1951.

R. Luthi-carter, S. A. Hanson, A. D. Strand, D. A. Bergstrom, W. Chun et al., Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain, Hum Mol Genet, vol.11, pp.1911-1926, 2002.

M. ,

L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper et al., Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, vol.87, pp.493-506, 1996.

R. L. Margolis, E. O'hearn, A. Rosenblatt, V. Willour, S. E. Holmes et al., A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion, Ann. Neurol, vol.50, pp.373-380, 2001.

R. L. Margolis, , 1993.

R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya et al., GeneReviews(®)

M. Sousa, C. , H. , and S. , Huntingtin: here, there, everywhere! J Huntingtons Dis 2, pp.395-403, 2013.

P. E. Marik and D. Kaplan, Aspiration pneumonia and dysphagia in the elderly, Chest, vol.124, pp.328-336, 2003.

M. Markianos, M. Panas, N. Kalfakis, and D. Vassilopoulos, Plasma testosterone in male patients with Huntington's disease: relations to severity of illness and dementia, Ann. Neurol, vol.57, pp.520-525, 2005.

A. Martin, History of dancing mania, Am J Clin Med, vol.30, pp.265-71, 1923.

B. Martin, E. Golden, A. Keselman, M. Stone, M. P. Mattson et al., Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body, Histol. Histopathol, vol.23, pp.237-250, 2008.

D. D. Martin, R. J. Heit, M. C. Yap, M. W. Davidson, M. R. Hayden et al., Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin, Hum. Mol. Genet, vol.23, pp.3166-3179, 2014.

I. Marty, M. Robert, M. Villaz, K. De-jongh, Y. Lai et al., Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle, Proc. Natl. Acad. Sci. U.S.A, vol.91, pp.2270-2274, 1994.

I. Marty, Triadin regulation of the ryanodine receptor complex, J. Physiol. (Lond.), vol.593, pp.3261-3266, 2015.

I. Marty and J. Fauré, Excitation-Contraction Coupling Alterations in Myopathies, J Neuromuscul Dis, vol.3, pp.443-453, 2016.

R. Mehanna, J. , and J. , Respiratory problems in neurologic movement disorders, Parkinsonism Relat. Disord, vol.16, pp.628-638, 2010.

L. B. Menalled and M. Chesselet, Mouse models of Huntington's disease, Trends Pharmacol. Sci, vol.23, pp.32-39, 2002.

L. B. Menalled, J. D. Sison, I. Dragatsis, S. Zeitlin, and M. Chesselet, Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats, J. Comp. Neurol, vol.465, pp.11-26, 2003.

L. Menalled and D. Brunner, Animal models of Huntington's disease for translation to the clinic: best practices, Mov. Disord, vol.29, pp.1375-1390, 2014.

J. R. Mcguire, J. Rong, S. Li, and X. Li, Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons, J. Biol. Chem, vol.281, pp.3552-3559, 2006.

M. Mielcarek, L. Inuabasi, M. K. Bondulich, T. Muller, G. F. Osborne et al., Dysfunction of the CNS-heart axis in mouse models of Huntington's disease, PLoS Genet, vol.10, issue.8, p.1004550, 2014.

M. Mielcarek, M. K. Bondulich, L. Inuabasi, S. A. Franklin, T. Muller et al., The Huntington's disease-related cardiomyopathy prevents a hypertrophic response in the R6/2 mouse model, PLoS One, vol.9, p.108961, 2014.

M. Mielcarek, Huntington's disease is a multi-system disorder, 2015.

M. Mielcarek, M. Toczek, C. J. Smeets, S. A. Franklin, M. K. Bondulich et al., HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy, PLoS Genet, vol.11, p.1005021, 2015.

M. Mielcarek, R. T. Smolenski, and M. Isalan, Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model, Front Physiol, vol.8, p.127, 2017.

M. J. Mihm, D. M. Amann, B. L. Schanbacher, R. A. Altschuld, J. A. Bauer et al., Cardiac dysfunction in the R6/2 mouse model of Huntington's disease. Neurobiol, Dis, vol.25, pp.297-308, 2007.

Â. Miranda, R. Lavrador, F. Júlio, C. Januário, M. Castelo-branco et al., Classification of Huntington's disease stage with support vector machines: A study on oculomotor performance, Behav Res Methods, vol.48, pp.1667-1677, 2016.

N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, Autophagy fights disease through cellular self-digestion, Nature, vol.451, pp.1069-1075, 2008.

F. Mochel, P. Charles, F. Seguin, J. Barritault, C. Coussieu et al., Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression, PLoS ONE, vol.2, p.647, 2007.

H. Moffitt, G. D. Mcphail, B. Woodman, C. Hobbs, and G. P. Bates, Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease, PLoS One, vol.4, p.8025, 2009.

A. E. Molero, E. E. Arteaga-bracho, C. H. Chen, M. Gulinello, M. L. Winchester et al., Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease, Proc Natl Acad Sci U S A, vol.113, pp.5736-5741, 2016.

N. Monnier, V. Procaccio, P. Stieglitz, and J. Lunardi, Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle, Am. J. Hum. Genet, vol.60, pp.1316-1325, 1997.

N. Monnier and J. Lunardi, , 2000.

, Ann. Biol. Clin, vol.58, pp.147-156

N. Monnier, N. B. Romero, J. Lerale, P. Landrieu, Y. Nivoche et al., Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor, Hum. Mol. Genet, vol.10, pp.2581-2592, 2001.

N. Monnier, A. Ferreiro, I. Marty, A. Labarre-vila, P. Mezin et al., A homozygous splicing mutation causing a depletion of skeletal muscle RYR11 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia, Hum. Mol. Genet, vol.12, pp.1171-1178, 2003.

N. Monnier, I. Marty, J. Faure, C. Castiglioni, C. Desnuelle et al., Null mutations causing depletion of the type 1 ryanodine receptor (RYR11) are commonly associated with recessive structural congenital myopathies with cores, Hum. Mutat, vol.29, pp.670-678, 2008.

A. Montoya, M. Pelletier, M. Menear, E. Duplessis, F. Richer et al., Episodic memory impairment in Huntington's disease: a meta-analysis, Neuropsychologia, vol.44, 1984.

A. Montoya, B. H. Price, M. Menear, and M. Lepage, Brain imaging and cognitive dysfunctions in Huntington's disease, J Psychiatry Neurosci, vol.31, pp.21-29, 2006.

R. C. Moore, F. Xiang, J. Monaghan, D. Han, Z. Zhang et al., Huntington disease phenocopy is a familial prion disease, Am. J. Hum. Genet, vol.69, pp.1385-1388, 2001.

V. Moresi, A. H. Williams, E. Meadows, J. M. Flynn, M. J. Potthoff et al., Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases, Cell, vol.143, pp.35-45, 2010.

J. E. Morgan and T. A. Partridge, Muscle satellite cells, Int. J. Biochem. Cell Biol, vol.35, pp.1151-1156, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-00181349

M. Mort, F. A. Carlisle, A. J. Waite, L. Elliston, N. D. Allen et al., Huntingtin Exists as Multiple Splice Forms in Human Brain, J Huntingtons Dis, vol.4, pp.161-171, 2015.

R. H. Myers, Huntington's disease genetics, NeuroRx, vol.1, pp.255-262, 2004.

J. Nasir, S. B. Floresco, J. R. O'kusky, V. M. Diewert, J. M. Richman et al., Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes, Cell, vol.81, pp.811-823, 1995.

C. Nehl, J. S. Paulsen, and H. S. Group, Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity, J. Nerv. Ment. Dis, vol.192, pp.72-74, 2004.

F. Niccolini and M. Politis, Neuroimaging in Huntington's disease, World J Radiol, vol.6, pp.301-312, 2014.

M. Nishi, K. Hashimoto, K. Kuriyama, S. Komazaki, M. Kano et al., Motor discoordination in mutant mice lacking junctophilin type 3, Biochem. Biophys. Res. Commun, vol.292, pp.318-324, 2002.

A. C. Nóbrega, B. Rodrigues, and A. Melo, Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients?, Parkinsonism Relat. Disord, vol.14, pp.646-648, 2008.

J. Ochaba, T. Lukacsovich, G. Csikos, S. Zheng, J. Margulis et al., Potential function for the Huntingtin protein as a scaffold for selective autophagy, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.16889-16894, 2014.

S. Oddoux, J. Brocard, A. Schweitzer, P. Szentesi, B. Giannesini et al., Triadin deletion induces impaired skeletal muscle function, J. Biol. Chem, vol.284, pp.34918-34929, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00516073

S. Oddoux, K. J. Zaal, V. Tate, A. Kenea, S. A. Nandkeolyar et al., Microtubules that form the stationary lattice of muscle fibers are dynamic and nucleated at Golgi elements, J. Cell Biol, vol.203, pp.205-213, 2013.

M. S. Okun, Huntington's disease: what we learned from the original essay, Neurologist, vol.9, pp.175-179, 2003.

A. L. Ørbeck, An early description of Huntington's chorea, Medical history, vol.3, issue.02, pp.165-168, 1959.

M. Orth, J. M. Cooper, G. P. Bates, and A. H. Schapira, Inclusion formation in Huntington's disease R6/2 mouse muscle cultures, J Neurochem, vol.87, pp.1-6, 2003.

A. Osseni, M. Sébastien, O. Sarrault, M. Baudet, Y. Couté et al., Triadin and CLIMP-63 form a link between triads and microtubules in muscle cells, J. Cell. Sci, vol.129, pp.3744-3755, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02135097

E. Oster, E. R. Dorsey, J. Bausch, A. Shinaman, E. Kayson et al., Fear of health insurance loss among individuals at risk for Huntington disease, Study Group PHAROS Investigators, vol.146, pp.2070-2077, 2008.

D. V. Otti, A. K. Hödl, C. M. Bonelli, A. Strele, B. Obermeyer-pietsch et al., Osteoporosis in Huntington's disease, Proceedings of the 2nd International Congress of Biological Psychiatry, 2007.

C. Paolini, M. Quarta, L. D'onofrio, C. Reggiani, and F. Protasi, Differential effect of calsequestrin ablation on structure and function of fast and slow skeletal muscle fibers, J. Biomed. Biotechnol, p.634075, 2011.

R. Pardo, M. Molina-calavita, G. Poizat, G. Keryer, S. Humbert et al., pARIS-HTT: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking, Mol Brain, vol.3, p.17, 2010.

K. Patton and . Thibodeau, Anthony's textbook of anatomy & physiology. Anthony's textbook of anatomy & physiology, 1224.

J. S. Paulsen, C. Nehl, K. F. Hoth, J. E. Kanz, M. Benjamin et al., Depression and stages of Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.17, pp.496-502, 2005.

J. S. Paulsen, D. R. Langbehn, J. C. Stout, E. Aylward, C. A. Ross et al., Detection of Huntington's disease decades before diagnosis: the Predict-HD study, Neurosurgery & Psychiatry, vol.79, issue.8, pp.874-880, 2008.

J. S. Paulsen, Functional imaging in Huntington's disease, Exp. Neurol, vol.216, pp.272-277, 2009.

J. S. Paulsen, Cognitive impairment in Huntington disease: diagnosis and treatment, Curr Neurol Neurosci Rep, vol.11, pp.474-483, 2011.

J. S. Paulsen, J. D. Long, H. J. Johnson, E. H. Aylward, C. A. Ross et al., Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study, Front Aging Neurosci, vol.6, p.78, 2014.

E. Penziner, J. K. Williams, C. Erwin, Y. Bombard, A. Wallis et al., Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease, Am. J. Med. Genet. B Neuropsychiatr. Genet, vol.147, pp.320-325, 2008.

A. Pichot, Histoire de la notion de gène. Flammarion : Paris, p.344, 1999.

B. Poreau, Mécanisme physiopathologique et spectre clinique liés aux mutations d'ECEL1, un gène majeur d'arthrogrypose. Thèse d'exercice de médecine : CHU Grenoble, 2014.

B. Poreau, De Pierre-Joseph Van Beneden à la médecine et l'écologie contemporaines: l'histoire du commensalisme, p.206, 2016.

B. Poreau, Progressive and self-limiting neurodegenerative disorders in Africa: a new prominent field of research led by South Africa but without strong health policy, Pan African Medical Journal, vol.23, issue.1, 2016.

D. F. Preisig, L. Kulic, M. Kruger, F. Wirth, J. Mcafoose et al., High-speed video gait analysis reveals early and characteristic locomotor phenotypes in mouse models of neurodegenerative movement disorders, Behav Brain Res, vol.311, pp.340-353, 2016.

T. Pringsheim, K. Wiltshire, L. Day, J. Dykeman, T. Steeves et al., The incidence and prevalence of Huntington's disease: a systematic review and metaanalysis, Mov. Disord, vol.27, pp.1083-1091, 2012.

F. Protasi, C. Paolini, and M. Dainese, Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke, J. Physiol. (Lond.), vol.587, pp.3095-3100, 2009.

Y. Qi, E. M. Ogunbunmi, E. A. Freund, A. P. Timerman, and S. Fleischer, FKbinding protein is associated with the ryanodine receptor of skeletal muscle in vertebrate animals, J. Biol. Chem, vol.273, pp.34813-34819, 1998.

J. Quigley, Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist, Curr Psychiatry Rep, vol.19, p.9, 2017.

S. Ramaswamy, J. L. Mcbride, and J. H. Kordower, Animal models of Huntington's disease, ILAR J, vol.48, pp.356-373, 2007.

H. Rangone, S. Humbert, and F. Saudou, Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?, Pathol. Biol, vol.52, pp.338-342, 2004.

A. Rasmussen, R. Macias, P. Yescas, A. Ochoa, G. Davila et al., Huntington disease in children: genotype-phenotype correlation, Neuropediatrics, vol.31, pp.190-194, 2000.

M. D. Rawlins, N. S. Wexler, A. R. Wexler, S. J. Tabrizi, I. Douglas et al., The Prevalence of Huntington's Disease, Neuroepidemiology, vol.46, pp.144-153, 2016.

A. Reyes, T. Cruickshank, M. Ziman, and K. Nosaka, Pulmonary function in patients with Huntington's disease, BMC Pulm Med, vol.14, p.89, 2014.

P. Ribaï, K. Nguyen, V. Hahn-barma, I. Gourfinkel-an, M. Vidailhet et al., Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients, Arch. Neurol, vol.64, pp.813-819, 2007.

R. R. Ribchester, D. Thomson, N. I. Wood, T. Hinks, T. H. Gillingwater et al., Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation, Eur J Neurosci, vol.20, pp.3092-3114, 2004.

A. O. Robbins, A. K. Ho, and R. A. Barker, Weight changes in Huntington's disease, Eur. J. Neurol, vol.13, p.7, 2006.

N. B. Romero, M. Herasse, N. Monnier, J. P. Leroy, D. Fischer et al., Clinical and histopathological aspects of central core disease associated and non-associated with RYR11 locus, Acta Myol, vol.24, pp.70-73, 2005.

R. A. Roos, Huntington's disease: a clinical review, Dialogues Clin Neurosci, vol.5, pp.191-197, 2007.

A. Rosenblatt, Understanding the psychiatric prodrome of Huntington disease, J. Neurol. Neurosurg. Psychiatr, vol.78, p.913, 2007.

D. Rossi, B. Vezzani, L. Galli, C. Paolini, L. Toniolo et al., A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates, Hum. Mutat, vol.35, pp.1163-1170, 2014.

D. Rossi, V. Barone, E. Giacomello, V. Cusimano, and V. Sorrentino, The sarcoplasmic reticulum: an organized patchwork of specialized domains, Traffic, vol.9, pp.1044-1049, 2008.

N. Roux-buisson, M. Cacheux, A. Fourest-lieuvin, J. Fauconnier, J. Brocard et al., Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human, Hum. Mol. Genet, vol.21, pp.2759-2767, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00763211

K. C. Rowe, J. S. Paulsen, D. R. Langbehn, K. Duff, L. J. Beglinger et al., Self-paced timing detects and tracks change in prodromal Huntington disease, Neuropsychology, vol.24, pp.435-442, 2010.

U. Rüb, J. P. Vonsattel, H. Heinsen, and H. Korf, The Neuropathology of Huntington´s disease: classical findings, recent developments and correlation to functional neuroanatomy, Adv Anat Embryol Cell Biol, vol.217, pp.1-146, 2015.

U. Rüb, K. Seidel, H. Heinsen, J. P. Vonsattel, W. F. Den-dunnen et al., , 2016.

, Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain, Brain Pathol, vol.26, pp.726-740

Y. Rui, Z. Xu, B. Patel, Z. Chen, D. Chen et al., Huntingtin functions as a scaffold for selective macroautophagy, Nat. Cell Biol, vol.17, pp.262-275, 2015.

Y. Rui, Z. Xu, B. Patel, A. M. Cuervo, and S. Zhang, HTT/Huntingtin in selective autophagy and Huntington disease: A foe or a friend within, Autophagy, vol.11, pp.858-860, 2015.

A. Ruzo, I. Ismailoglu, M. Popowski, T. Haremaki, G. F. Croft et al., Discovery of novel isoforms of huntingtin reveals a new hominid-specific exon, PLoS ONE, vol.10, 2015.

C. Saft, J. Zange, J. Andrich, K. Müller, K. Lindenberg et al., Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease, Mov. Disord, vol.20, pp.674-679, 2005.

P. R. Sanberg, H. C. Fibiger, and R. F. Mark, Body weight and dietary factors in Huntington's disease patients compared with matched controls, Med. J. Aust, vol.1, pp.407-409, 1981.

M. Samsó, 3D Structure of the Dihydropyridine Receptor of Skeletal Muscle, Eur J Transl Myol, vol.25, p.4840, 2015.

J. Sassone, C. Colciago, G. Cislaghi, V. Silani, and A. Ciammola, Huntington's disease: the current state of research with peripheral tissues, Exp. Neurol, vol.219, pp.385-397, 2009.

K. Sathasivam, C. Hobbs, M. Turmaine, L. Mangiarini, A. Mahal et al., Formation of polyglutamine inclusions in non-CNS tissue, Hum Mol Genet, vol.8, pp.813-822, 1999.

F. Saudou, H. , and S. , The Biology of Huntingtin, Neuron, vol.89, pp.910-926, 2016.

R. I. Scahill, N. Z. Hobbs, M. J. Say, N. Bechtel, S. M. Henley et al., Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy, Hum Brain Mapp, vol.34, pp.519-529, 2013.

A. H. Schapira, Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia, Biochim Biophys Acta, vol.1410, pp.159-170, 1999.

S. Schiaffino and C. Reggiani, Fiber Types in Mammalian Skeletal Muscles, Physiological Reviews, vol.91, pp.1447-1531, 2011.

G. Schilling, M. W. Becher, A. H. Sharp, H. A. Jinnah, K. Duan et al., Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin, Hum. Mol. Genet, vol.8, pp.397-407, 1999.

A. M. Schroeder, H. B. Wang, S. Park, M. C. Jordan, F. Gao et al., Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease, PLoS ONE, vol.11, p.147269, 2016.

A. I. Seixas, S. E. Holmes, H. Takeshima, A. Pavlovich, N. Sachs et al., Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis, Ann. Neurol, vol.71, pp.245-257, 2012.

A. H. Sharp, S. J. Loev, G. Schilling, S. H. Li, X. J. Li et al., Widespread expression of Huntington's disease gene (IT15) protein product, Neuron, vol.14, pp.1065-1074, 1995.

P. She, Z. Zhang, D. Marchionini, W. C. Diaz, T. J. Jetton et al., Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease, Am J Physiol Endocrinol Metab, vol.301, pp.49-61, 2011.

X. Shen, C. Franzini-armstrong, J. R. Lopez, L. R. Jones, Y. M. Kobayashi et al., Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle, J. Biol. Chem, vol.282, pp.37864-37874, 2007.

D. U. Silverthorn, Physiologie humaine: une approche intégrée, 2007.

A. C. Solomon, J. C. Stout, S. A. Johnson, D. R. Langbehn, E. H. Aylward et al., Verbal episodic memory declines prior to diagnosis in Huntington's disease, Neuropsychologia, vol.45, pp.1767-1776, 2007.

S. A. Sørensen and K. Fenger, Causes of death in patients with Huntington's disease and in unaffected first degree relatives, J. Med. Genet, vol.29, pp.911-914, 1992.

V. Sorrentino, Sarcoplasmic reticulum: structural determinants and protein dynamics, Int. J. Biochem. Cell Biol, vol.43, pp.1075-1078, 2011.

F. Squitieri, A. Falleni, M. Cannella, S. Orobello, F. Fulceri et al., Abnormal morphology of peripheral cell tissues from patients with Huntington disease, J Neural Transm, vol.117, pp.77-83, 2010.

G. Stevanin, H. Fujigasaki, A. Lebre, A. Camuzat, C. Jeannequin et al., Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes, Brain, vol.126, pp.1599-1603, 2003.

G. Stevanin and A. Brice, Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4), Cerebellum, vol.7, pp.170-178, 2008.

J. C. Stout, J. S. Paulsen, S. Queller, A. C. Solomon, K. B. Whitlock et al., Neurocognitive signs in prodromal Huntington disease, Neuropsychology, vol.25, pp.1-14, 2011.

N. Stoy and E. Mckay, Weight loss in Huntington's disease, Ann. Neurol, vol.48, pp.130-131, 2000.

A. D. Strand, A. K. Aragaki, D. Shaw, T. Bird, J. Holton et al., Gene expression in Huntington's disease skeletal muscle: a potential biomarker, Hum Mol Genet, vol.14, pp.1863-1876, 2005.

M. Suzuki, Y. Nagai, K. Wada, and T. Koike, Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin, Biochem. Biophys. Res. Commun, vol.429, pp.18-23, 2012.

J. Szpyt, N. Lorenzon, C. F. Perez, E. Norris, P. D. Allen et al., Three-Dimensional Localization of the and Subunits and of the II-III Loop in the Skeletal Muscle L-type Ca2+ Channel, Journal of Biological Chemistry, vol.287, pp.43853-43861, 2012.

S. J. Tabrizi, D. R. Langbehn, B. R. Leavitt, R. A. Roos, A. Durr et al., Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, Lancet Neurol, vol.8, pp.791-801, 2009.

S. J. Tabrizi, R. I. Scahill, G. Owen, A. Durr, B. R. Leavitt et al., Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data, Lancet Neurol, vol.12, pp.637-649, 2013.

H. Takeshima, M. Iino, H. Takekura, M. Nishi, J. Kuno et al., Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene, Nature, vol.369, pp.556-559, 1994.

T. Tang, H. Tu, E. Y. Chan, A. Maximov, Z. Wang et al., Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1, Neuron, vol.39, pp.227-239, 2003.

T. Tang, E. Slow, V. Lupu, I. G. Stavrovskaya, M. Sugimori et al., Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.2602-2607, 2005.

T. Tang, C. Guo, H. Wang, X. Chen, and I. Bezprozvanny, Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington's disease mouse model, J. Neurosci, vol.29, pp.1257-1266, 2009.

L. M. Thompson, An expanded role for wild-type huntingtin in neuronal transcription, Nat. Genet, vol.35, pp.13-14, 2003.

J. C. Thompson, E. Poliakoff, A. C. Sollom, E. Howard, D. Craufurd et al., Automaticity and attention in Huntington's disease: when two hands are not better than one, Neuropsychologia, vol.48, pp.171-178, 2010.

J. G. Tidball, Mechanisms of muscle injury, repair, and regeneration, Compr Physiol, vol.1, pp.2029-2062, 2011.

P. Tijskens, L. R. Jones, and C. Franzini-armstrong, Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins, J. Mol. Cell. Cardiol, vol.35, pp.961-974, 2003.

Y. Toyoshima, M. Yamada, O. Onodera, M. Shimohata, C. Inenaga et al., SCA17 homozygote showing Huntington's diseaselike phenotype, Ann. Neurol, vol.55, pp.281-286, 2004.

Y. Toyoshima, O. Onodera, M. Yamada, S. Tsuji, and H. Takahashi, , 1993.

;. Spinocerebellar, R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace et al., Ataxia Type 17, GeneReviews(®)

A. Trejo, M. Boll, M. E. Alonso, A. Ochoa, and L. Velásquez, Use of oral nutritional supplements in patients with Huntington's disease, Nutrition, vol.21, pp.889-894, 2005.

A. Trejo, R. M. Tarrats, M. E. Alonso, M. Boll, A. Ochoa et al., Assessment of the nutrition status of patients with Huntington's disease, Nutrition, vol.20, pp.192-196, 2004.

T. Tukamoto, N. Nukina, K. Ide, and I. Kanazawa, Huntington's disease gene product, huntingtin, associates with microtubules in vitro, Brain Res Mol Brain Res, vol.51, pp.8-14, 1997.

A. E. Twelvetrees, E. Y. Yuen, I. L. Arancibia-carcamo, A. F. Macaskill, P. Rostaing et al., Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin, Neuron, vol.65, pp.53-65, 2010.

, Unified Huntington's Disease Rating Scale: reliability and consistency, Mov. Disord, vol.11, pp.136-142, 1996.

I. Unmack-larsen, T. Vinther-jensen, A. Gade, J. E. Nielsen, and A. Vogel, Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers, J Int Neuropsychol Soc, vol.21, pp.193-202, 2015.

S. Ursu, A. Alekov, N. Mao, and K. Jurkat-rott, ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro, Acta Myol, vol.31, pp.144-153, 2012.

P. A. Valadão, B. C. De-aragão, J. N. Andrade, M. P. Magalhães-gomes, G. Foureaux et al., Muscle atrophy is associated with cervical spinal motoneuron loss in BACHD mouse model for Huntington's disease, Eur. J. Neurosci, vol.45, pp.785-796, 2017.

L. M. Valor, Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective, Mol. Neurobiol, vol.51, pp.406-423, 2015.

J. M. Van-raamsdonk, Z. Murphy, D. M. Selva, R. Hamidizadeh, J. Pearson et al., Testicular degeneration in Huntington disease, Neurobiol. Dis, vol.26, pp.512-520, 2007.

K. Varani, M. P. Abbracchio, M. Cannella, G. Cislaghi, P. Giallonardo et al., Aberrant A2A receptor function in peripheral blood cells in Huntington's disease, FASEB J, vol.17, pp.2148-2150, 2003.

K. Varani, A. Bachoud-lévi, C. Mariotti, A. Tarditi, M. P. Abbracchio et al., Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages, Neurobiol. Dis, vol.27, pp.36-43, 2007.

C. Verny, A. Bachoud-lévi, A. Durr, C. Goizet, J. Azulay et al., A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease, Mov. Disord, 2017.

J. P. Van-vugt, K. K. Piet, L. J. Vink, S. Siesling, A. H. Zwinderman et al., Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis, Mov. Disord, vol.19, pp.659-667, 2004.

G. Wang, X. Liu, M. A. Gaertig, S. Li, and X. Li, Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis, Proc. Natl. Acad. Sci. U.S.A, vol.113, pp.3359-3364, 2016.

S. C. Warby, R. K. Graham, M. R. Hayden, R. A. Pagon, M. P. Adam et al., Huntington Disease, GeneReviews(®), 1993.

C. W. Waters, G. Varuzhanyan, R. J. Talmadge, and A. A. Voss, Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction, Proc Natl Acad Sci U S A, vol.110, pp.9160-9165, 2013.

S. Watt and S. Bhimji, Malignant Hyperthermia, StatPearls, 2017.

H. Wendt, , 1960.

, Z Arztl Fortbild (Jena), vol.54, pp.1146-1150

A. Wexler, E. J. Wild, and S. J. Tabrizi, George Huntington: a legacy of inquiry, empathy and hope, Brain, vol.139, pp.2326-2333, 2016.

V. C. Wheeler, J. K. White, C. A. Gutekunst, V. Vrbanac, M. Weaver et al., Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice, Hum. Mol. Genet, vol.9, pp.503-513, 2000.

J. M. Wilmshurst, S. Lillis, H. Zhou, K. Pillay, H. Henderson et al., RYR11 mutations are a common cause of congenital myopathies with central nuclei, Ann. Neurol, vol.68, pp.717-726, 2010.

H. Wilson, R. De-micco, F. Niccolini, and M. Politis, Molecular Imaging Markers to Track Huntington's Disease Pathology, Front Neurol, vol.8, p.11, 2017.

N. I. Wood, S. J. Sawiak, G. Buonincontri, Y. Niu, A. D. Kane et al., Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease, J Huntingtons Dis, vol.1, pp.57-64, 2012.

Y. C. Wong and E. L. Holzbaur, The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation, J. Neurosci, vol.34, pp.1293-1305, 2014.

J. Wu, Z. Yan, Z. Li, X. Qian, S. Lu et al., Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 Å resolution, Nature, vol.537, pp.191-196, 2016.

F. Xiang, E. W. Almqvist, M. Huq, A. Lundin, M. R. Hayden et al., A Huntington disease-like neurodegenerative disorder maps to chromosome 20p, Am. J. Hum. Genet, vol.63, pp.1431-1438, 1998.

T. C. Yaltho, J. , and J. , The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms, Mov. Disord, vol.26, pp.1582-1592, 2011.

Z. Yan, X. Bai, C. Yan, J. Wu, Z. Li et al., Structure of the rabbit ryanodine receptor RyR11 at near-atomic resolution, Nature, vol.517, pp.50-55, 2015.

N. Yanagisawa, The spectrum of motor disorders in Huntington's disease, Clin Neurol Neurosurg, vol.94, pp.182-184, 1992.

D. Zala, M. Hinckelmann, H. Yu, M. M. Lyra-da-cunha, G. Liot et al., Vesicular glycolysis provides on-board energy for fast axonal transport, Cell, vol.152, pp.479-491, 2013.

R. Zalk, O. B. Clarke, A. Georges, R. A. Grassucci, S. Reiken et al., Structure of a mammalian ryanodine receptor, Nature, vol.517, pp.44-49, 2015.

S. Zeitlin, J. P. Liu, D. L. Chapman, V. E. Papaioannou, and A. Efstratiadis, Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue, Nat. Genet, vol.11, pp.155-163, 1995.

M. M. Zeron, O. Hansson, N. Chen, C. L. Wellington, B. R. Leavitt et al., Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease, Neuron, vol.33, pp.849-860, 2002.

L. Zhang, J. Kelley, G. Schmeisser, Y. M. Kobayashi, and L. R. Jones, Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane, J. Biol. Chem, vol.272, pp.23389-23397, 1997.

H. Zhang, Q. Li, R. K. Graham, E. Slow, M. R. Hayden et al., Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease, Neurobiol. Dis, vol.31, pp.80-88, 2008.

D. Zielonka, I. Piotrowska, and M. Mielcarek, Cardiac dysfunction in Huntington's Disease, Exp Clin Cardiol, vol.20, pp.2547-2554, 2014.

D. Zielonka, I. Piotrowska, J. T. Marcinkowski, and M. Mielcarek, Skeletal muscle pathology in Huntington's disease, Front Physiol, vol.5, p.380, 2014.

D. Zielonka, M. Mielcarek, and G. B. Landwehrmeyer, Update on Huntington's disease: advances in care and emerging therapeutic options, Parkinsonism Relat. Disord, vol.21, pp.169-178, 2015.

C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza et al., Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes, Nat. Genet, vol.35, pp.76-83, 2003.

, Animaux tenus en captivité (domestiques ou non domestiques) Oui

, Animaux fournis Mus musculus

, Votre propre établissement utilisateur fournit-il tout ou partie des animaux du projet ? Oui Un autre établissement utilisateur fournit-il tout ou partie des animaux du projet ? Non Les animaux sont-ils des animaux réutilisés d'un projet précédent? Non

. Joubert, types d'expérience avec 2 temps différents) composés chacun de 10 souris contrôles et 10 souris avec baisse de huntingtine pour atteindre la puissance statistique décrite au paragraphe 3.3.5. Au total, 120 souris sont nécessaires par modèle, Pour chacun des deux modèles, 6 lots sont nécessaires, 2013.

, Indiquez à quel(s) stade(s) de développement les animaux seront utilisés et le justifier Les animaux seront utilisés à l'âge adulte

, Indiquer pour chaque espèce les points limites adaptés, suffisamment prédictifs et précoces pour permettre de limiter la douleur à son minimum

. Wang, Du paracétamol sera administré (200mg/kg) après l'injection. La nourriture hydratée sera proposée pour faciliter l'alimentation. Concernant la seconde procédure, il n'est pas attendu d'atrophie majeure, PNAS, 2016.